Caricamento...
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
Oncolytic immunotherapeutics (OIs) are viruses designed to preferentially replicate in and lyse cancer cells, thereby triggering antitumor immunity. Numerous oncolytic platforms are currently in clinical development. Here we review preclinical and clinical experience with Pexa-Vec (pexastimogene dev...
Salvato in:
| Pubblicato in: | Oncolytic Virother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918374/ https://ncbi.nlm.nih.gov/pubmed/27512667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S59640 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|